Candriam Equities L Biotech.C-H EUR Acc/ LU1120766206 /
NAV5/30/2024 | Chg.+1.9700 | Type of yield | Investment Focus | Investment company |
---|---|---|---|---|
193.2600EUR | +1.03% | reinvestment | Equity | Candriam ▶ |
Funds documents
Date | Document | Year | Language | Filesize |
---|---|---|---|---|
6/2/2024 | Public WebStation Live Factsheet | 2024 | English | - |
3/1/2024 | PRIIP Key Information Document | 2024 | German | 269.02 KB |
12/31/2023 | Account statment | 2023 | English | 5,416.37 KB |
12/31/2023 | Account statment | 2023 | German | 4,732.66 KB |
9/11/2023 | Prospectus | 2023 | English | 3,638.77 KB |
9/11/2023 | Prospectus | 2023 | German | 3,801.35 KB |
6/30/2023 | Semi-annual report | 2023 | English | 1,982.78 KB |
6/30/2023 | Semi-annual report | 2023 | German | 2,086.39 KB |
12/1/2022 | Key Investor Information | 2022 | German | 362.40 KB |